Novartis taps Iya Khalil, physicist co-founder of GNS Healthcare, to lead AI Innovation Center
At the turn of the millennium, finishing up her PhD in theoretical physics, Iya Khalil found the career paths in front of her wanting. Academic postings were tough to get, but she couldn’t envision applying all she’s learned to predict stocks on Wall Streets, as some of her contemporaries did.
She was working on models of two-dimensional electron gas, a topic in solid-state physics, when she met Colin Hill, the fellow Cornell physicist with whom she would later start a company named Gene Network Sciences.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.